Health
UK to start HEAL-COVID trial to reduce mortality,re-admission rate among Covid survivors – BusinessLine
This will be carried out in collaboration with the Liverpool Clinical Trials Centre at the University of Liverpool and Wrexham-based clinical trial technology firm…
The United Kingdom is set to initiate a drug trial called HEAL-COVID in an effort to alleviate the mortality rate and readmission cases in patients who have previously been hospitalised with the novel coronavirus.
According to the report by Clinical Trials Arena, data collated by the UK Office for National Statistics indicated that 29 per cent of Covid-19 hospitalised patients were readmitted within six months. While more than 12 per cent died within the same period.
So, the new trial will help…
-
General14 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News23 hours agoBetty’s Burgers National Burger Day
-
General15 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News23 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws